Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
0.9492
+0.0195 (2.10%)
At close: Apr 23, 2025, 4:00 PM
1.040
+0.091 (9.57%)
Pre-market: Apr 24, 2025, 6:48 AM EDT

Esperion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
188433340459306725
Upgrade
Market Cap Growth
27.49%27.49%-25.93%49.97%-57.77%-55.52%
Upgrade
Enterprise Value
634848757815726687
Upgrade
Last Close Price
0.952.202.996.235.0026.00
Upgrade
Forward PE
-16.60----
Upgrade
PS Ratio
0.531.302.926.083.903.19
Upgrade
PB Ratio
-0.48-1.11-0.75-1.42-1.55-7.54
Upgrade
EV/Sales Ratio
1.912.556.5110.799.263.02
Upgrade
EV/EBITDA Ratio
11.6515.58----
Upgrade
EV/EBIT Ratio
11.6615.59----
Upgrade
Debt / Equity Ratio
-1.52-1.52-1.19-1.56-2.63-3.77
Upgrade
Debt / EBITDA Ratio
10.2910.29----
Upgrade
Asset Turnover
1.211.210.510.240.210.80
Upgrade
Inventory Turnover
1.431.432.574.194.76-
Upgrade
Quick Ratio
0.910.910.842.173.853.37
Upgrade
Current Ratio
1.371.371.292.674.493.68
Upgrade
Return on Assets (ROA)
12.37%12.37%-42.86%-35.64%-36.31%-26.73%
Upgrade
Return on Capital (ROIC)
23.58%23.58%-72.90%-44.78%-45.52%-36.13%
Upgrade
Return on Capital Employed (ROCE)
55.70%55.70%----
Upgrade
Earnings Yield
-27.55%-11.94%-61.54%-50.90%-87.91%-19.81%
Upgrade
FCF Yield
-12.76%-5.53%-39.85%-38.09%-86.18%-11.87%
Upgrade
Buyback Yield / Dilution
-81.54%-81.54%-55.26%-129.76%-5.20%-1.42%
Upgrade
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q